SABCS 2022 Conference Coverage
Playback speed
10 seconds
SABCS 2022 Phase III SWOG S1207 Trial: Evaluating Adjuvant ET +/- 1 Year of Everolimus in Patients With High-Risk HR+/HER2- BC
By
SABCS 2022 Conference Coverage
FEATURING
Mariana Chavez Mac Gregor
By
SABCS 2022 Conference Coverage
FEATURING
Mariana Chavez Mac Gregor
62 views
December 14, 2022
Comments 0
Login to view comments.
Click here to Login
Videos